UNDERWRITING SUPPORTERS
LEAD SUPPORTERS
MAJOR SUPPORTERS
SUPPORTERS
GENERAL SUPPORTER
AWARD SUPPORTERS
CONFERENCE PROFILE
This multidisciplinary conference will be attended by those who are leading the discovery and drug development effort against cancer worldwide. Overall, attendees at the Molecular Targets conference include senior level research scientists, heads of discovery and drug development from both industry and academia, as well as those in international and U.S. marketing of oncology products and those working on in-licensing and pipeline development.
In Boston, over 3,000 researchers from 40 different countries - more than half of those from industry - are scheduled to attend the conference. At the last U.S. conference on Molecular Targets in 2007, more than 200 companies sent scientific and management delegations. Leading scientists and administrators from the NCI, FDA, and other governmental and regulatory agencies, along with a host of senior leaders from major academic research centers, cancer centers, and pharmaceutical and biotech companies in the U.S., Europe, and Asia will participate this year.
SUPPORT OPPORTUNITIES
AACR welcomes support from corporations, foundations, and other organizations that are interested in helping to defray a portion of the cost of presenting this important international conference. Numerous benefits for supporters are provided in recognition of their financial assistance. For additional information regarding support opportunities, please follow the links below or contact David Goodman in the AACR Development Department at (215) 440-9300, ext. 133 or
david.goodman@aacr.org.
* - Adobe Acrobat Reader required